Matrix metalloproteinases in intestinal fibrosis and fibrostenosing Crohn&#39;s disease: Current evidence, mechanistic hypotheses, and translational challenges.

andecaliximab (GS-5745) - āshibio

http://www.ncbi.nlm.nih.gov/pubmed/42185740

Don W Powell; Kevin M Lopez; Qingjie Li; Rongliwen Ou; Thierry Kochkarian

May 26, 2026